For people with confirmed absorption problems or documented deficiency, injectable methylcobalamin represents the gold standard
In a case series study from New York of people with overt neurological symptoms from B12 malabsorption, MMA levels ranged from 755 to 187,000 nmol/l (Lindenbaum, 1988)
lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks
Chairon House offers in-clinic or telehealth free consultations
This is particularly important for individuals with conditions that interfere with B12 absorption, such as pernicious anemia, gastrointestinal disorders like celiac disease or Crohns disease, or those who have undergone certain types of gastrointestinal surgery
Cardiovascular Benefits: Reduces oxidative damage in cardiac tissue Stabilizes cardiac rhythm Enhances endothelial progenitor cell activity Reduces atherosclerotic progression in animal models Its longevity-enhancing properties may support overall cardiovascular resilience and reduce vascular aging
